RBM4 Antibodies

Santa Cruz Biotechnology delivers a wide array of RBM4 monoclonal antibodies for research focused on understanding RNA-binding motif protein 4 (RBM4). RBM4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RBM4, or RNA-binding motif protein 4, regulates gene expression and alternative splicing, playing a significant role in cellular processes such as differentiation and proliferation. RBM4 has been identified as a key factor in various biological pathways, making it relevant for both normal physiology and disease states, including cancer. Investigating RBM4 can reveal important insights into molecular mechanisms underlying cellular processes. Research utilizing RBM4 monoclonal antibodies has contributed to understanding post-transcriptional regulation and RNA processing. Scientists exploring RBM4's role in development and disease progression can benefit from specific detection methods in their experimental approaches. Santa Cruz Biotechnology monoclonal antibodies for RBM4 support researchers worldwide in advancing scientific understanding of RNA biology and disease mechanisms.